Vitiligo Skin Biomarkers Associated With Favorable Therapeutic Response

Vitiligo is an acquired depigmentation skin disease caused by immune-mediated death of melanocytes. The most common treatment for vitiligo is narrow band ultraviolet B phototherapy, which often is combined with topical therapies such as tacrolimus. However, patients’ responses to these treatments sh...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Qianli, Zhang, Guohong, Su, Mingwan, Leung, Gigi, Lui, Harvey, Zhou, Pingyu, Wu, Yan, Zhou, Joshua, Xu, Jinhua, Zhang, Xuejun, Zhou, Youwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015777/
https://www.ncbi.nlm.nih.gov/pubmed/33815367
http://dx.doi.org/10.3389/fimmu.2021.613031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015777/
https://www.ncbi.nlm.nih.gov/pubmed/33815367
http://dx.doi.org/10.3389/fimmu.2021.613031

Ejemplares similares